Neurological and Mental Health Symptoms Associated with Post-COVID-19 Disability in a Sample of Patients Discharged from a COVID-19 Ward: A Secondary Analysis.

COVID-19 WHODAS-12 anxiety brain impairment cognitive dysfunction disability fatigue hypogeusia hyposmia

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 04 2022
Historique:
received: 14 02 2022
revised: 30 03 2022
accepted: 31 03 2022
entrez: 12 4 2022
pubmed: 13 4 2022
medline: 14 4 2022
Statut: epublish

Résumé

Recent studies suggest that COVID-19 survivors may experience long-term health consequences: in particular, neurological and mental health symptoms might be associated with long-term negative outcomes. This study is a secondary analysis of a larger cohort study and aims to determine the extent to which neurological and mental health sequelae are associated with survivors' disability. Participants include COVID-19 survivors, with no pre-morbid brain conditions, who were discharged from the COVID-19 Unit of the ASST Spedali Civili Hospital between February and April 2020. At an average of 3.5 months after discharge, they were submitted to a neurological examination and completed the WHO Disability Assessment Schedule (WHODAS-12), the Hospital Anxiety and Depression Score, the Pittsburgh Sleep Quality Index and the Montreal Cognitive Assessment. Multivariable regression analysis was carried out to analyze variables that explain WHODAS-12 variation. In total, 83 patients (63 males, average age 66.9, 95% CI: 64.2-69.7) were enrolled; average WHODAS-12 was 13.2 (95% CI: 9.7-16.6). Cognitive dysfunction, anxiety, fatigue, and hyposmia/hypogeusia explained 28.8% of WHODAS-12 variation. These findings underline the importance and need for longitudinal follow-up assessments after recovery from COVID-19 and suggest the need for early rehabilitation of residual symptoms to enhance patients' functioning.

Identifiants

pubmed: 35409924
pii: ijerph19074242
doi: 10.3390/ijerph19074242
pmc: PMC8998950
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Br J Anaesth. 2021 Mar;126(3):e110-e113
pubmed: 33413976
Alzheimers Res Ther. 2019 May 10;11(1):43
pubmed: 31077241
Eur Respir J. 2020 Jul 2;56(1):
pubmed: 32398306
SN Compr Clin Med. 2020;2(8):1053-1056
pubmed: 32838162
Bull World Health Organ. 2010 Nov 1;88(11):815-23
pubmed: 21076562
Ann N Y Acad Sci. 2021 Feb;1486(1):90-111
pubmed: 33009668
J Intern Med. 2021 Sep;290(3):621-631
pubmed: 33533521
Respiration. 2022;101(2):132-141
pubmed: 34569550
Eur J Phys Rehabil Med. 2017 Apr;53(2):155-168
pubmed: 28382807
Pathogens. 2022 Feb 19;11(2):
pubmed: 35215212
J Neurol Sci. 2022 Mar 15;434:120162
pubmed: 35121209
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Eur J Phys Rehabil Med. 2021 Jun;57(3):443-450
pubmed: 33393278
Sleep Med. 2020 Nov;75:315-325
pubmed: 32950013
J Am Geriatr Soc. 2021 Oct;69(10):2778-2780
pubmed: 34019707
J Am Geriatr Soc. 1968 May;16(5):622-6
pubmed: 5646906
Eur J Intern Med. 2021 Oct;92:55-70
pubmed: 34167876
Lancet Infect Dis. 2022 Apr;22(4):e102-e107
pubmed: 34951953
SN Compr Clin Med. 2021;3(8):1704-1706
pubmed: 34036244
Acta Psychiatr Scand. 2014 Dec;130(6):439-51
pubmed: 25219393
Am J Phys Med Rehabil. 2020 Jul;99(7):571-572
pubmed: 32371624
NeuroRehabilitation. 2021;48(4):469-480
pubmed: 33998551
PLoS One. 2020 Dec 11;15(12):e0243882
pubmed: 33306721
Int J Environ Res Public Health. 2021 Oct 29;18(21):
pubmed: 34769934
Neurol Sci. 2021 Dec;42(12):4903-4907
pubmed: 34523082
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Psychiatry Res. 2012 Aug 30;199(1):24-30
pubmed: 22503380
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34580069
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
PLoS One. 2022 Mar 8;17(3):e0264331
pubmed: 35259179
SN Compr Clin Med. 2020;2(10):1758-1760
pubmed: 32905109
Sleep Med. 2021 Jan;77:346-347
pubmed: 32595107
Brain Behav Immun Health. 2020 Dec;9:100163
pubmed: 33111132
Acta Biomed. 2020 Jul 20;91(9-S):7-18
pubmed: 32701911
SN Compr Clin Med. 2020;2(12):2702-2714
pubmed: 33251483
Brain Behav Immun. 2020 Jul;87:49-50
pubmed: 32304883
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211010994
pubmed: 33880955
J Crit Care. 2020 Aug;58:29-33
pubmed: 32330817
Lancet. 2020 Apr 4;395(10230):1110-1111
pubmed: 32220279
Clin Neurol Neurosurg. 2020 Jul;194:105921
pubmed: 32422545
Sci Rep. 2021 Jun 23;11(1):13153
pubmed: 34162913
Int J Environ Res Public Health. 2021 Jun 03;18(11):
pubmed: 34205086
BMC Neurol. 2011 Mar 24;11:37
pubmed: 21435231
Int Clin Psychopharmacol. 2000 Nov;15(6):319-28
pubmed: 11110007
Mov Disord. 2017 Jul;32(7):1025-1034
pubmed: 28509336
Eur J Phys Rehabil Med. 2020 Jun;56(3):335-338
pubmed: 32329589
Eur J Phys Rehabil Med. 2021 Apr;57(2):189-198
pubmed: 33448756

Auteurs

Martina Cacciatore (M)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Alberto Raggi (A)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Andrea Pilotto (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Viviana Cristillo (V)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Erika Guastafierro (E)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Claudia Toppo (C)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Francesca G Magnani (FG)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Davide Sattin (D)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Arianna Mariniello (A)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Fabiola Silvaggi (F)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Stefano Cotti Piccinelli (S)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Nicola Zoppi (N)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Giulio Bonzi (G)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Stefano Gipponi (S)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Ilenia Libri (I)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Michela Bezzi (M)

Respiratory Unit, ASST Spedali Civili di Brescia, 25121 Brescia, Italy.

Paolo Martelletti (P)

Department of Clinical and Molecular Medicine, Sapienza University, 00185 Rome, Italy.
Regional Referral Headache Center, Sant'Andrea University Hospital, 00189 Rome, Italy.

Matilde Leonardi (M)

Neurology, Public Health Disability Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, 25121 Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH